Huby T, Dachet C, Lawn R M, Wickings J, Chapman M J, Thillet J
INSERM, Unité 551, Dyslipoprotéinémies, Athérosclérose: Génétique, Métabolisme et Thérapeutique, Hôpital de la Pitié, 83 Boulevard de l'Hôpital, Paris 75651 Cedex 13, France.
J Biol Chem. 2001 Jun 22;276(25):22209-14. doi: 10.1074/jbc.M102204200. Epub 2001 Apr 11.
Lp(a) concentrations vary considerably among individuals and are primarily determined by the apo(a) gene locus. We have previously shown that mean plasma Lp(a) levels in the chimpanzee are significantly higher than those observed in humans (Doucet, C., Huby, T., Chapman, J., and Thillet, J. (1994) J. Lipid Res 35, 263-270). To evaluate the possibility that this difference may result from a high level of expression of chimpanzee apo(a), we cloned and sequenced 1.4 kilobase (kb) of the 5'-flanking region of the gene and compared promoter activity to that of its human counterpart. Sequence analysis revealed 98% homology between chimpanzee and human apo(a) 5' sequences; among the differences observed, two involved polymorphic sites associated with Lp(a) levels in humans. The TTTTA repeat located 1.3 kb 5' of the apo(a) gene, present in a variable number of copies (n = 5-12) in humans, is uniquely present as four copies in the chimpanzee sequence. The second position concerns the +93 C>T polymorphism that creates an additional ATG start codon in the human apo(a) gene, thereby impairing translation efficiency. In chimpanzee, this position did not appear polymorphic, and a base difference at position +94 precluded the presence of an additional ATG. In transient transfection assays, the chimpanzee apo(a) promoter exhibited a 5-fold elevation in transcriptional activity as compared with its human counterpart. This marked difference in activity was maintained with either 1.4 kb of 5' sequence or the minimal promoter region -98 to +141 of the human and chimpanzee apo(a) genes. Using point mutational analyses, nucleotides present at positions -3, -2, and +8 (relative to the start site of transcription) were found to be essential for the high transcription efficiency of the chimpanzee apo(a) promoter. High transcriptional activity of the chimpanzee apo(a) gene may therefore represent a key factor in the elevated plasma Lp(a) levels characteristic of this non-human primate.
个体之间的脂蛋白(a)[Lp(a)]浓度差异很大,且主要由载脂蛋白(a)[apo(a)]基因位点决定。我们之前已经表明,黑猩猩的平均血浆Lp(a)水平显著高于人类(杜塞特,C.,胡比,T.,查普曼,J.,以及蒂耶,J.(1994年)《脂质研究杂志》35卷,263 - 270页)。为了评估这种差异可能是由于黑猩猩apo(a)高水平表达所致的可能性,我们克隆并测序了该基因5'侧翼区域的1.4千碱基(kb),并将启动子活性与其人类对应物进行了比较。序列分析显示黑猩猩和人类apo(a) 5'序列之间有98%的同源性;在观察到的差异中,有两个涉及与人类Lp(a)水平相关的多态性位点。位于apo(a)基因5'端1.3 kb处的TTTTA重复序列,在人类中以可变数量的拷贝存在(n = 5 - 12),在黑猩猩序列中独特地以四个拷贝存在。第二个位点涉及+93 C>T多态性,该多态性在人类apo(a)基因中产生了一个额外的ATG起始密码子,从而损害了翻译效率。在黑猩猩中,这个位置没有表现出多态性,并且+94位的碱基差异排除了额外ATG的存在。在瞬时转染实验中,与人类对应物相比,黑猩猩apo(a)启动子的转录活性提高了5倍。无论是1.4 kb的5'序列还是人类和黑猩猩apo(a)基因的最小启动子区域 -98至+141,这种显著的活性差异都得以保持。通过点突变分析发现,相对于转录起始位点,位于 -3、 -2和 +8位的核苷酸对于黑猩猩apo(a)启动子的高转录效率至关重要。因此,黑猩猩apo(a)基因的高转录活性可能是这种非人类灵长类动物血浆Lp(a)水平升高的一个关键因素。